June 30th, 2009
Posted by: admin
ATLANTA (MedPage Today) — Zanamivir (Relenza) should be the preferred treatment for patients with influenza-like illness, whether infection is caused by a seasonal virus or the pandemic H1N1 virus, an advisory committee to the CDC said.
This entry was posted
on Tuesday, June 30th, 2009 at 3:15 am and is filed under Health news.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.